Johns Hopkins Gazette | May 11, 2009
Gazette masthead
   About The Gazette Search Back Issues Contact Us    
The newspaper of The Johns Hopkins University May 11, 2009 | Vol. 38 No. 34
New Evidence Ties Gene to Alzheimer's

By Maryalice Yakutchik
Johns Hopkins Medicine

Of dozens of candidates potentially involved in increasing a person's risk for the most common type of Alzheimer's disease, which affects more than 5 million Americans over the age of 65, one gene that keeps grabbing the attention of Johns Hopkins researchers makes a protein called neuroglobin.

Adding to a growing body of evidence about the importance of this protein for the health of the aging brain, researchers at the McKusick-Nathans Institute of Genetic Medicine at the Johns Hopkins University School of Medicine canvassed the genetic neighborhood of neuroglobin and, for the first time in a human population, linked variation there with a risk for Alzheimer's.

Ever so slight genetic variations between individuals can and do influence the amounts of particular proteins that each specific gene ultimately produces. In this case, the team has found that individuals with genetic variations equating to less neuroglobin production have an increased risk for Alzheimer's.

"An intriguing part of this study was the high levels of neuroglobin that we found in the Alzheimer's brain, which was exactly the opposite from what we expected," said Dimitrios Avramopoulos, an associate professor in the Institute of Genetic Medicine and the Department of Psychiatry at Johns Hopkins.

Referring to data published in Neurobiology of Aging, Avramopoulos said that his team measured levels of gene product in 56 different samples of human brain tissue: 30 from confirmed cases of Alzheimer's and 26 without brain disease.

The scientists found that neuroglobin levels decreased with advancing age, which, Avramopoulos points out, is consistent with risk of Alzheimer's increasing with advancing age. They also found that levels of neuroglobin were lower in women than in men, which is consistent with the fact that women have a slightly higher risk of Alzheimer's. About two times as many patients in the general population with Alzheimer's are women, a statistic which, in part, can be attributed to the fact that women live longer and therefore have more of a chance to get Alzheimer's. Having corrected for that disparity, researchers have noted a slightly higher risk in women than in men.

They say they were surprised to find that neuroglobin levels were higher in the brain tissue from Alzheimer's patients than that of the control group.

Counterintuitive though it seemed at first, it actually makes sense, Avramopoulos says, especially in light of previously published studies that indicated a protective function for neuroglobin and showed that mouse brains respond to stress — in this case, a lack of oxygen — by producing more neuroglobin.

The scientists think that neuroglobin production also ramps up in reaction to the insult of the Alzheimer's disease. They hypothesize that maybe in some people it's simply not enough of a protective response to effectively defend the brain. "The older we get, the less neuroglobin this particular gene produces in our brains — unless something stimulates the gene to produce more," Avramopoulos said. "That something could be a stressor such as a lack of oxygen resulting from stoke or emphysema, for instance. And it looks like it also could be Alzheimer's disease.

"Further work on this gene will likely provide intervention targets for a multitude of very common conditions, including Alzheimer's," he said.

In addition to Avramopoulos, authors of the paper are Megan Szymanski, Ruihua Wang, M. Danielle Fallin and Susan S. Bassett, all of Johns Hopkins.


The Gazette | The Johns Hopkins University | Suite 540 | 901 S. Bond St. | Baltimore, MD 21231 | 443-287-9900 |